IE800693L - Cancer diagnostic test - Google Patents

Cancer diagnostic test

Info

Publication number
IE800693L
IE800693L IE800693A IE69380A IE800693L IE 800693 L IE800693 L IE 800693L IE 800693 A IE800693 A IE 800693A IE 69380 A IE69380 A IE 69380A IE 800693 L IE800693 L IE 800693L
Authority
IE
Ireland
Prior art keywords
serum
cancer
diagnostic test
cancer diagnostic
dna
Prior art date
Application number
IE800693A
Other versions
IE49981B1 (en
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Publication of IE800693L publication Critical patent/IE800693L/en
Publication of IE49981B1 publication Critical patent/IE49981B1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4704—Inhibitors; Supressors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/50—Fibroblast growth factors [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Sink And Installation For Waste Water (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Inhibitor protein X in its substantially pure form having the following characterising properties: (i) it is a protein isolatable from human blood serum; (ii) it has a molecular weight of about 64,000 daltons and a Pl of 5.9; (iii) it inhibits bleomycin-induced degradation of PM-2 DNA by binding to the DNA; and (iv) it is found in lower concentrations in the serum of human beings having cancer than in the serum of cancer-free human beings. h [GB2047712A]
IE693/80A 1979-04-10 1980-04-03 A human serum dna-binding protein and diagnostic test method IE49981B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2873279A 1979-04-10 1979-04-10

Publications (2)

Publication Number Publication Date
IE800693L true IE800693L (en) 1980-10-10
IE49981B1 IE49981B1 (en) 1986-01-22

Family

ID=21845111

Family Applications (1)

Application Number Title Priority Date Filing Date
IE693/80A IE49981B1 (en) 1979-04-10 1980-04-03 A human serum dna-binding protein and diagnostic test method

Country Status (24)

Country Link
JP (1) JPS55143441A (en)
KR (1) KR830002502A (en)
AR (1) AR222700A1 (en)
AT (1) AT365343B (en)
AU (1) AU536522B2 (en)
BE (1) BE882669A (en)
CH (1) CH644453A5 (en)
DE (1) DE3013837A1 (en)
DK (1) DK149980A (en)
ES (1) ES8103380A1 (en)
FI (1) FI801078A (en)
FR (1) FR2454099A1 (en)
GB (1) GB2047712B (en)
GR (1) GR67692B (en)
HU (1) HU183122B (en)
IE (1) IE49981B1 (en)
IL (1) IL59772A (en)
IT (1) IT1143135B (en)
LU (1) LU82345A1 (en)
NL (1) NL8002094A (en)
NO (1) NO801018L (en)
PH (1) PH15637A (en)
SE (1) SE8002602L (en)
ZA (1) ZA802141B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3524644A1 (en) * 1985-07-10 1987-01-15 Heyl Chem Pharm UNDULIN AND ITS PEPTIDE FRAGMENTS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE

Also Published As

Publication number Publication date
NO801018L (en) 1980-10-13
FR2454099B1 (en) 1984-01-27
IT1143135B (en) 1986-10-22
HU183122B (en) 1984-04-28
FR2454099A1 (en) 1980-11-07
JPS55143441A (en) 1980-11-08
KR830002502A (en) 1983-05-30
AR222700A1 (en) 1981-06-15
AU5719380A (en) 1980-10-16
ZA802141B (en) 1981-04-29
IL59772A (en) 1983-05-15
ATA195780A (en) 1981-05-15
NL8002094A (en) 1980-10-14
AU536522B2 (en) 1984-05-10
GB2047712B (en) 1983-02-23
ES490396A0 (en) 1981-02-16
BE882669A (en) 1980-10-06
GB2047712A (en) 1980-12-03
PH15637A (en) 1983-03-11
CH644453A5 (en) 1984-07-31
FI801078A (en) 1980-10-11
LU82345A1 (en) 1980-12-16
GR67692B (en) 1981-09-07
AT365343B (en) 1982-01-11
DE3013837A1 (en) 1980-10-30
DK149980A (en) 1980-10-11
IE49981B1 (en) 1986-01-22
IL59772A0 (en) 1980-06-30
SE8002602L (en) 1980-12-09
IT8048370A0 (en) 1980-04-09
ES8103380A1 (en) 1981-02-16

Similar Documents

Publication Publication Date Title
CA2090981A1 (en) Immunological method for the determination of a haemoglobin derivative
KR880700668A (en) Composition of amino acid chelates for delivery to specific biological tissue sites
SE8000469L (en) TISSUE BINDING AND PROCEDURE FOR ITS MANUFACTURING AND USING THE BINDING AGENT
SE8501022D0 (en) FORMAT CREATES AND PROCEDURES FOR ITS PREPARATION
DE69231473D1 (en) IMMUNOCHEMICAL DETECTION OF END PRODUCTS OF ADVANCED GLYCOSYLATION IN VIVO
IE801902L (en) Copolymer
CA2178752A1 (en) N-Terminally Chemically Modified Protein Compositions and Methods
IE780912L (en) A glycoprotain and process for the production thereof
Small Jr et al. Peptide differences of rabbit γG-immunoglobulin light chains controlled by allelic genes
EP0247730A3 (en) Antibodies, their preparation and use and products containing them
CA2140794A1 (en) Assay for the determination of protein in a biological sample
ES8507692A1 (en) Chromogenic tracers for use in an assay.
IE781198L (en) Glycoprotein isolation
AU567747B2 (en) Early detection of mammalian pregnancy
CA2112776A1 (en) Process for inhibiting activity of endotoxin
IE39627L (en) Hair and skin protection
DE3667061D1 (en) New protein isolated from blood, process for preparing said protein, antibodies against said new protein, and pharmaceutical compositions containing said protein or said antibodies
EP0155104A3 (en) Free analyte assay
IE800693L (en) Cancer diagnostic test
York et al. Interaction of fragments of fibrinogen with insolubilized fibrin monomers (activated fibrinogen)
EP0300381A3 (en) Immunological detection of herbicides
JPS5569595A (en) Novel substance having fibrinolytic activity, remedy for thrombotic embolic disease comprising it, and its preparation
Iwata et al. Existence of two kinds of thiol protease inhibitors in rat serum
EP0373613A3 (en) Pyridine-3-percarboxylic acid monopersulfate
ES8505915A1 (en) Perfumery compounds and their preparation.